Results 221 to 230 of about 13,475,824 (303)

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

Arthritis Care &Research, EarlyView.
Catherine Deffendall, Jodi Backalar, Elizabeth Acevedo Zapata, Adriana Della Porta, Lorin Bibb, Tyler Reese, Charlotte M. Brown   +6 more
wiley   +1 more source

Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower Atherosclerotic Cardiovascular Disease Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) is the cornerstone of systemic lupus erythematosus (SLE) management with benefits extending beyond SLE control, including protection against atherosclerotic cardiovascular disease (ASCVD). Although HCQ blood levels reflect recent exposure and long‐term intake reflects medication adherence, the impact of longitudinal ...
Shivani Garg, Murray Urowitz, Charlie Dentz, Niriti Adhikari, Fauzia Hollnagel, Nathalie Costedoat‐Chalumeau   +5 more
wiley   +1 more source

Use of failure mode and effects analysis for risk analysis of investigational drug products management in clinical trials. [PDF]

Am J Health Syst Pharm
Zhang B, Song M, Wang Z, Zhou Y, Pang X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug management of neutrophilic dermatoses

Expert Review of Clinical Pharmacology, 2017
Neutrophilic dermatoses are a heterogenous group of chronic, cutaneous inflammatory conditions characterized by the accumulation of neutrophils in the skin and by systemic inflammation. Neutrophilic dermatoses can be idiopathic or associated with other inflammatory or systemic diseases, including the group of the hereditary, autoinflammatory syndromes.
S. Garcovich, C. De Simone, E. Berti, A. Marzano   +3 more
semanticscholar   +4 more sources

Drug management

Atrial Fibrillation in Practice, 2020
G. Lip
semanticscholar   +2 more sources

Drug-resistant epilepsy: Definition, pathophysiology, and management.

Journal of Neurological Sciences, 2023
There are currently >51 million people with epilepsy (PWE) in the world and every year >4.9 million people develop new-onset epilepsy. The cornerstone of treatment in PWE is drug therapy with antiseizure medications (ASMs).
B. Mesraoua, Francesco Brigo, S. Lattanzi, B. Abou-Khalil, H. A. Hail, A. Asadi-Pooya   +5 more
semanticscholar   +1 more source

Managing Drug Use

British Journal of Addiction, 1989
SummaryThis study of Class A drug users in Nottingham identifies a local drug economy with specific demand and supply characteristics. With reference to demand, data are presented on users’purchasing power and purchasing behaviour, including drug re‐sales and the use of credit. Crude elasticity relationships are discussed.
D K, Whynes, P T, Bean, J A, Giggs, C, Wilkinson   +3 more
openaire   +2 more sources

Drug allergy management in the elderly

Current Opinion in Allergy & Clinical Immunology, 2021
Purpose of review Drug allergy management has previously not been emphasized in the elderly. However, the geriatric population poses several unique characteristics, challenges for drug allergy testing and considerations in the management.
Jane C Y, Wong, Philip H, Li
openaire   +2 more sources

Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.

European journal of internal medicine, 2021
Drug-induced liver injury (DILI) is an important but rare adverse event which can range from mild liver enzyme elevations to liver failure, transplantation or death.
HK Björnsson, ES Björnsson
semanticscholar   +1 more source